Skip to main content Skip to navigation

News

  1. Glasses on a newspaper

    Oral v IV steroids for relapses

    30 June 2015

    A new study at 13 centres in France has found no that there was no difference on outcomes whether someone took oral or intravenous steroids to treat relapses.
    Read more…

  1. Small sample dishes

    Oral v IV steroids for relapses

    30 June 2015

    A new study at 13 centres in France has found no that there was no difference on outcomes whether someone took oral or intravenous steroids to treat relapses.
    Read more…

  1. MS Trust news board

    Ocrelizumab clinical trial results announced

    30 June 2015

    Ocrelizumab was better than beta interferon at reducing the number of relapses, slowing the rate of disability progression and reducing the number of lesions seen on MRI scans according to trial results announced by the pharmaceutical company Roche. Read more…

  1. Beaker and flask pouring blue liquid

    Neurologists move toward earlier treatment for MS

    22 June 2015

    People with relapsing remitting MS should be considering starting disease modifying treatment as early as possible and be active partners in treatment choices according to newly revised guidelines published today by the Association of British Neurologists (ABN). Read more…